Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,691 annual reports · 4,011 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 443 of 641 · 7,691 filings

  • Ames National (ATLO) FY2024 10-K risk factors
    30 risks

    Ames National Corp's risks focus heavily on credit concentration in Iowa agriculture and commercial real estate. Interest rate spreads and liquidity management drive operating results. Technology, cybersecurity, and compliance with extensive banking regulations are key ongoing concerns.

    Filed Mar 12, 2025
  • Braemar Hotels & Resorts (BHR) FY2024 10-K risk factors
    93 risks

    Invests heavily in luxury hotels concentrated in specific U.S. metropolitan areas, relying entirely on external advisor Ashford LLC for management.

    Filed Mar 12, 2025
  • Smartbird (BIRD) FY2024 10-K risk factors
    73 risks

    Smartbird faces persistent net losses and significant restructuring efforts, including transitioning its international model to third-party distributors in multiple regions. The company relies heavily on a limited number of overseas contract manufacturers, particularly in Vietnam, creating acute supply chain and inventory risks. Its focus on sustainable materials and ESG targets exposes it to fluctuating raw material costs and shifting regulatory expectations.

    Filed Mar 12, 2025
  • BRT Apartments (BRT) FY2024 10-K risk factors
    34 risks

    Geographic concentration in the Southeast and Texas drives regional vulnerability.

    Filed Mar 12, 2025
  • Bank7 (BSVN) FY2024 10-K risk factors
    24 risks

    Concentration in regional markets, specifically Oklahoma and Texas, heavily impacts loan performance and commercial real estate exposure. High concentration in hospitality loans and energy sector credit exposure creates specific industry-level vulnerabilities. Insider control by management and the Haines Family Trusts represents 55.8% of common stock.

    Filed Mar 12, 2025
  • Bowman Consulting Group (BWMN) FY2024 10-K risk factors
    58 risks

    Bowman Consulting faces intense competition, heavy dependence on qualified engineering personnel, and cyclical demand tied closely to the U.S. homebuilding market. The company relies heavily on accretive acquisitions and government contracts, exposing it to integration challenges, backlog uncertainty, and restrictive credit covenants.

    Filed Mar 12, 2025
  • Cardlytics (CDLX) FY2024 10-K risk factors
    55 risks

    Cardlytics depends heavily on Chase, Bank of America, and Wells Fargo for purchase data and bank-partner platform distribution. Revenue dropped 10.0% to $278.3 million in 2024, with net losses reaching $189.3 million. The company faces high customer concentration and reliance on a nascent transaction-based marketing industry.

    Filed Mar 12, 2025
  • Cohen (COHN) FY2024 10-K risk factors
    77 risks

    Cohen & Co's risks center heavily on its exposure to SPACs, mortgage market services, and principal trading activities. Volatile credit conditions, clearing dependence on Pershing LLC, and key senior management dependencies dominate the risk profile.

    Filed Mar 12, 2025
  • Consumer Portfolio Services (CPSS) FY2024 10-K risk factors
    31 risks

    Company relies heavily on debt financing, securitizations, and warehouse credit facilities to operate its subprime auto loan business. Operations are vulnerable to subprime default rates, interest rate fluctuations, economic recessions, and geographic concentration in California, Florida, and Texas. Compliance with consumer protection regulations and cybersecurity threats to customer data present significant ongoing risks.

    Filed Mar 12, 2025
  • Cheetah Net Supply Chain Service (CTNT) FY2024 10-K risk factors
    44 risks

    Cheetah Net is transitioning from parallel-import vehicle sales to logistics and warehousing services following the Edward acquisition.

    Filed Mar 12, 2025
  • electroCore (ECOR) FY2024 10-K risk factors
    144 risks

    This filing reflects an initial public reporting year dominated by commercial expansion into direct-to-consumer channels and the pending NURO acquisition. Key growth drivers include the Truvaga app-enabled wellness product, gConcierge/gCDirect cash-pay programs, and TAC-STIM military sales. Heavy customer concentration exists with VA facilities representing 70.6% of total revenue in 2024.

    Filed Mar 12, 2025
  • Ernexa Therapeutics (ERNA) FY2024 10-K risk factors
    36 risks

    Capital requirements and ongoing operating losses dominate the risk profile alongside strong reliance on in-licensed technology from Factor Limited.

    Filed Mar 12, 2025

Companies covered

4,011 companies

371 more under A